Global sales of plant extracts reached US$10.14 billion in 2006, reaching US$33.32 billion in 2016, with an average annual growth rate of 12.63%. Plant extracts can be used as raw materials and are widely used in downstream industries such as food, beverages, pharmaceuticals, health products, and cosmetics. The following analysis of market size of plant extracts.
According to the market scale analysis of plant extracts, the export volume of China's plant extract industry accounted for more than 80% of the industry's total revenue. Export is the main way to drive the industry's development. In 2001, the export volume of Chinese plant extracts was only 191 million US dollars, and it was exported by 2010. It has reached 815 million U.S. dollars. In 2011, the export volume of phytosanitary products in China was US$1.13 billion, an increase of 47% year-on-year. It became the first category of Chinese medicine to exceed US$1 billion in exports, and it became the main driving force for the growth of exports of Chinese medicines. 2018 Research Report on the Depth of Plant Extracts in the Global and Chinese Markets It is expected that the market size of China's plant extracts industry will reach 24.9 billion yuan in 2018, and by 2022 the industry scale will exceed 34.1 billion yuan.
The Chinese plant extractive industry is an emerging industry in general and is in the development stage. In recent years, the worldwide appeal for [return to nature" has been on the rise, and plant extracts have attracted more and more attention from the pharmaceutical and food industries. It has become one of the fastest-growing industries in the country, and the market scale has developed leaps and bounds. The inherent development potential. Now from the two major trends to analyze the market size of plant extracts.
1. It will become a new hot spot in the world drug market and R&D
According to the market scale analysis of plant extracts, 25% of the world's chemical drugs are originally derived from plants. The best known are aspirin, quinine, digitalis, vinblastine and taxol. At present, there are two trends in the research and development of botanical drugs: one is the component research method represented by the United States (ie, the western medicine method, the monomolecular structure drug extracted from plants), and the second is the EU countries represented by Germany. Component research method. Compared with the component research method, this method is more convenient for commercial development and more in line with the reality of the Chinese botanical industry.
As the European market for botanical drugs has developed from several aspects such as policies and regulations, technological level, and consumer psychology, domestic companies entering the international botanicals market through the EU are a convenient way.
2. The demand for natural health products will continue to grow
Studies in recent years have demonstrated that a large number of "modern diseases" such as coronary heart disease, cancer, hypertension, and diabetes in modern society have a great relationship with people's daily diet. Analysis of the market size of plant extracts, people realized that certain natural plant extracts can have health care and even have the role of preventing and treating certain diseases. It is better to use natural health foods to prevent diseases after taking medicines after illnesses.
Demand for phytochemicals is growing internationally. Demand from consumers for products made from organically grown herbs continues to grow, and this trend will continue; there is an increasing number of botanical formulas with sufficient scientific arguments that will help close the gap between health food stores and the mass market. The market scale analysis of plant extracts shows that the market has a higher degree of preference for natural medicines or ingredients, and the prospects for export of Chinese plant extracts are good. With the continued introduction of favorable industrial support policies, the industry will continue to maintain a high-speed development status. It is estimated that by 2022 The industry scale will exceed 34.1 billion yuan.
Organic Herb Inc.(OHI) is a developer, manufacturer , exporter and primary supplier of plant extracts, nutraceutical ingredients, effective components of chinese herbs and related products to the pharmaceuticals, beverage , health food and cosmetics industries. If need, pls contact us without hesitation.